Research Article
Clinical Significance of Circulating Tumor Cells (CTCs) and Survivin on Predicting Prognosis in Thyroid Cancer Patients
Table 1
Relationship between the presence of circulating tumor cells (CTCs) and the clinical features of thyroid cancer.
| | Number of cases | CTC-positive (%) | CTC-negative (%) | | values |
| | Age | | | | | | | ≤60 years old | 93 (56.7%) | 54 (58.1%) | 39 (42.9%) | 1.72 | 0.46 | | >60 years old | 71 (43.3%) | 52 (73.3%) | 19 (26.7%) | | Gender | | | | | | | Female | 104 (63.4%) | 62 (59.6%) | 12 (40.5%) | 0.015 | 0.56 | | Male | 60 (36.6%) | 30 (50.0%) | 30 (50.0%) | | Pathological subtypes | | | | | 0.001 | | PTC | 73 (44.5%) | 12 (16.4%) | 61 (83.6%) | 10.63 | | | FTC | 60 (36.6%) | 14 (23.3%) | 6 (76.7%) | | MTC | 12 (7.3% | 7 (58.3%) | 5 (41.6%) | | PDTC | 10 (6.1%) | 9 (90.0%) | 1 (10.0%) | | ATC | 9 (5.5) | 9 (100.0%) | 0 (0.00%) | | TNM stages | | | | | | | I | 101 (61.4%) | 9 (8.9%) | 92 (91.1%) | 10.63 | 0.001 | | II | 30 (18.4%) | 15 (50.0%) | 15 (50.0%) | | III | 22 (13.5%) | 18 (81.8%) | 4 (18.2%) | | IV | 11 (6.7%) | 11 (100.0%) | 0 (0.00%) |
|
|
CTC: circulating tumor cell; PTC: papillary thyroid cancer; FTC: follicular thyroid cancer; MTC: medullary thyroid cancer; PDTC: poorly differentiated thyroid cancer; ATC: anaplastic thyroid cancer.
|
